glp-1 obesity market news today Agonists Weight Loss Drugs Report, 2025-2030 India's obesity and diabetes market

While Ozempic and Wegovy will be fairly similar since they are both Semaglutide GLP-1, Mounjaro differs slightly in that much higher doses are required for use as a weight loss medication and is the newest on the market of these options, but comes with almost the same risks and side effects

Conclusions This retrospective cohort study showed that while GLP-1 RA use was associated with a slight increase in incident DR, fewer patients experienced progression to sight-threatening stages of DR, developed DR complications, or required invasive treatments

WFKD serves as an adjunctive therapy, playing a positive role (95)

LeanGBB (Gamma-Butyrobetaine Ethyl Ester HCl) 25mg